List of Tables
Table 1. Checkpoint Inhibitors for Treating Cancer CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
Table 2. Checkpoint Inhibitors for Treating Cancer Market Trends
Table 3. Checkpoint Inhibitors for Treating Cancer Market Drivers
Table 4. Checkpoint Inhibitors for Treating Cancer Market Challenges
Table 5. Checkpoint Inhibitors for Treating Cancer Market Restraints
Table 6. Global Checkpoint Inhibitors for Treating Cancer Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. India Checkpoint Inhibitors for Treating Cancer Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Checkpoint Inhibitors for Treating Cancer Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. India Checkpoint Inhibitors for Treating Cancer Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Key Manufacturers of Checkpoint Inhibitors for Treating Cancer, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Checkpoint Inhibitors for Treating Cancer Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Checkpoint Inhibitors for Treating Cancer Revenue Share by Manufacturer, 2018-2023
Table 13. Global Checkpoint Inhibitors for Treating Cancer Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Checkpoint Inhibitors for Treating Cancer Sales Share by Manufacturer, 2018-2023
Table 15. Global Checkpoint Inhibitors for Treating Cancer Price by Manufacturer (2018-2023) & (USD/Unit)
Table 16. Global Checkpoint Inhibitors for Treating Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Checkpoint Inhibitors for Treating Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Checkpoint Inhibitors for Treating Cancer as of 2022)
Table 18. Global Key Manufacturers of Checkpoint Inhibitors for Treating Cancer, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Checkpoint Inhibitors for Treating Cancer, Product Offered and Application
Table 20. Global Key Manufacturers of Checkpoint Inhibitors for Treating Cancer, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Checkpoint Inhibitors for Treating Cancer in India, Ranked by Revenue (2022) & (US$ million)
Table 23. India Checkpoint Inhibitors for Treating Cancer Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Checkpoint Inhibitors for Treating Cancer Revenue Share by Players, (2018-2023)
Table 25. India Checkpoint Inhibitors for Treating Cancer Sales by Players, (K Units), (2018-2023)
Table 26. India Checkpoint Inhibitors for Treating Cancer Sales Share by Players, (2018-2023)
Table 27. Global Checkpoint Inhibitors for Treating Cancer Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 28. Global Checkpoint Inhibitors for Treating Cancer Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Checkpoint Inhibitors for Treating Cancer Sales in Volume Forecast by Region (2024-2029) & (K Units)
Table 30. Global Checkpoint Inhibitors for Treating Cancer Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Checkpoint Inhibitors for Treating Cancer Sales in Value Forecast by Region (2024-2029) & (US$ Million)
Table 32. Americas Checkpoint Inhibitors for Treating Cancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. Americas Checkpoint Inhibitors for Treating Cancer Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Checkpoint Inhibitors for Treating Cancer Sales in Value by Country (2024-2029) & (US$ Million)
Table 35. Americas Checkpoint Inhibitors for Treating Cancer Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Checkpoint Inhibitors for Treating Cancer Sales in Volume by Country (2024-2029) & (K Units)
Table 37. EMEA Checkpoint Inhibitors for Treating Cancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. EMEA Checkpoint Inhibitors for Treating Cancer Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Checkpoint Inhibitors for Treating Cancer Sales in Value by Country (2024-2029) & (US$ Million)
Table 40. EMEA Checkpoint Inhibitors for Treating Cancer Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Checkpoint Inhibitors for Treating Cancer Sales in Volume by Country (2024-2029) & (K Units)
Table 42. APAC Checkpoint Inhibitors for Treating Cancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. APAC Checkpoint Inhibitors for Treating Cancer Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Checkpoint Inhibitors for Treating Cancer Sales in Value by Country (2024-2029) & (US$ Million)
Table 45. APAC Checkpoint Inhibitors for Treating Cancer Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Checkpoint Inhibitors for Treating Cancer Sales in Volume by Country (2024-2029) & (K Units)
Table 47. Bristol-Myers Squibb(BMS) Company Information
Table 48. Bristol-Myers Squibb(BMS) Description and Business Overview
Table 49. Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 50. Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Product
Table 51. Bristol-Myers Squibb(BMS) Recent Development
Table 52. Merck Company Information
Table 53. Merck Description and Business Overview
Table 54. Merck Checkpoint Inhibitors for Treating Cancer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 55. Merck Checkpoint Inhibitors for Treating Cancer Product
Table 56. Merck Recent Development
Table 57. Roche Company Information
Table 58. Roche Description and Business Overview
Table 59. Roche Checkpoint Inhibitors for Treating Cancer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 60. Roche Checkpoint Inhibitors for Treating Cancer Product
Table 61. Roche Recent Development
Table 62. Key Raw Materials Lists
Table 63. Raw Materials Key Suppliers Lists
Table 64. Checkpoint Inhibitors for Treating Cancer Customers List
Table 65. Checkpoint Inhibitors for Treating Cancer Distributors List
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Checkpoint Inhibitors for Treating Cancer Product Picture
Figure 2. Global Checkpoint Inhibitors for Treating Cancer Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Checkpoint Inhibitors for Treating Cancer Market Size 2018-2029 (US$ Million)
Figure 4. Global Checkpoint Inhibitors for Treating Cancer Sales 2018-2029 (K Units)
Figure 5. India Checkpoint Inhibitors for Treating Cancer Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 6. India Checkpoint Inhibitors for Treating Cancer Market Size 2018-2029 (US$ Million)
Figure 7. India Checkpoint Inhibitors for Treating Cancer Sales 2018-2029 (K Units)
Figure 8. India Checkpoint Inhibitors for Treating Cancer Market Share in Global, in Value (US$ Million) 2018-2029
Figure 9. India Checkpoint Inhibitors for Treating Cancer Market Share in Global, in Volume (K Units) 2018-2029
Figure 10. Checkpoint Inhibitors for Treating Cancer Report Years Considered
Figure 11. Product Picture of PD-1 Inhibitors
Figure 12. Product Picture of PD-L1 Inhibitors
Figure 13. Product Picture of CTLA-4 Inhibitors
Figure 14. Global Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2022 & 2029
Figure 15. Global Checkpoint Inhibitors for Treating Cancer Sales in Value by Type (2018-2029) & (US$ Million)
Figure 16. Global Checkpoint Inhibitors for Treating Cancer Sales Market Share in Value by Type (2018-2029)
Figure 17. Global Checkpoint Inhibitors for Treating Cancer Sales by Type (2018-2029) & (K Units)
Figure 18. Global Checkpoint Inhibitors for Treating Cancer Sales Market Share in Volume by Type (2018-2029)
Figure 19. Global Checkpoint Inhibitors for Treating Cancer Price by Type (2018-2029) & (USD/Unit)
Figure 20. India Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2022 & 2029
Figure 21. India Checkpoint Inhibitors for Treating Cancer Sales in Value by Type (2018-2029) & (US$ Million)
Figure 22. India Checkpoint Inhibitors for Treating Cancer Sales Market Share in Value by Type (2018-2029)
Figure 23. India Checkpoint Inhibitors for Treating Cancer Sales by Type (2018-2029) & (K Units)
Figure 24. India Checkpoint Inhibitors for Treating Cancer Sales Market Share in Volume by Type (2018-2029)
Figure 25. India Checkpoint Inhibitors for Treating Cancer Price by Type (2018-2029) & (USD/Unit)
Figure 26. Product Picture of Melanoma Treatment
Figure 27. Product Picture of Bladder Cancer Treatment
Figure 28. Product Picture of Other
Figure 29. Global Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2022 & 2029
Figure 30. Global Checkpoint Inhibitors for Treating Cancer Sales in Value by Application (2018-2029) & (US$ Million)
Figure 31. Global Checkpoint Inhibitors for Treating Cancer Sales Market Share in Value by Application (2018-2029)
Figure 32. Global Checkpoint Inhibitors for Treating Cancer Sales by Application (2018-2029) & (K Units)
Figure 33. Global Checkpoint Inhibitors for Treating Cancer Sales Market Share in Volume by Application (2018-2029)
Figure 34. Global Checkpoint Inhibitors for Treating Cancer Price by Application (2018-2029) & (USD/Unit)
Figure 35. India Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2022 & 2029
Figure 36. India Checkpoint Inhibitors for Treating Cancer Sales in Value by Application (2018-2029) & (US$ Million)
Figure 37. India Checkpoint Inhibitors for Treating Cancer Sales Market Share in Value by Application (2018-2029)
Figure 38. India Checkpoint Inhibitors for Treating Cancer Sales by Application (2018-2029) & (K Units)
Figure 39. India Checkpoint Inhibitors for Treating Cancer Sales Market Share in Volume by Application (2018-2029)
Figure 40. India Checkpoint Inhibitors for Treating Cancer Price by Application (2018-2029) & (USD/Unit)
Figure 41. Americas Checkpoint Inhibitors for Treating Cancer Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 42. Americas Checkpoint Inhibitors for Treating Cancer Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 43. Americas Checkpoint Inhibitors for Treating Cancer Sales by Type (2018-2029) & (K Units)
Figure 44. Americas Checkpoint Inhibitors for Treating Cancer Sales Market Share in Volume by Type (2018-2029)
Figure 45. Americas Checkpoint Inhibitors for Treating Cancer Sales by Application (2018-2029) & (K Units)
Figure 46. Americas Checkpoint Inhibitors for Treating Cancer Sales Market Share in Volume by Application (2018-2029)
Figure 47. United States Checkpoint Inhibitors for Treating Cancer Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 48. Canada Checkpoint Inhibitors for Treating Cancer Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 49. Mexico Checkpoint Inhibitors for Treating Cancer Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Checkpoint Inhibitors for Treating Cancer Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 51. EMEA Checkpoint Inhibitors for Treating Cancer Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 52. EMEA Checkpoint Inhibitors for Treating Cancer Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 53. EMEA Checkpoint Inhibitors for Treating Cancer Sales by Type (2018-2029) & (K Units)
Figure 54. EMEA Checkpoint Inhibitors for Treating Cancer Sales Market Share in Volume by Type (2018-2029)
Figure 55. EMEA Checkpoint Inhibitors for Treating Cancer Sales by Application (2018-2029) & (K Units)
Figure 56. EMEA Checkpoint Inhibitors for Treating Cancer Sales Market Share in Volume by Application (2018-2029)
Figure 57. Europe Checkpoint Inhibitors for Treating Cancer Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 58. Middle East Checkpoint Inhibitors for Treating Cancer Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 59. Africa Checkpoint Inhibitors for Treating Cancer Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 60. China Checkpoint Inhibitors for Treating Cancer Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 61. China Checkpoint Inhibitors for Treating Cancer Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 62. China Checkpoint Inhibitors for Treating Cancer Sales by Type (2018-2029) & (K Units)
Figure 63. China Checkpoint Inhibitors for Treating Cancer Sales Market Share in Volume by Type (2018-2029)
Figure 64. China Checkpoint Inhibitors for Treating Cancer Sales by Application (2018-2029) & (K Units)
Figure 65. China Checkpoint Inhibitors for Treating Cancer Sales Market Share in Volume by Application (2018-2029)
Figure 66. APAC Checkpoint Inhibitors for Treating Cancer Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 67. APAC Checkpoint Inhibitors for Treating Cancer Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 68. APAC Checkpoint Inhibitors for Treating Cancer Sales by Type (2018-2029) & (K Units)
Figure 69. APAC Checkpoint Inhibitors for Treating Cancer Sales Market Share in Volume by Type (2018-2029)
Figure 70. APAC Checkpoint Inhibitors for Treating Cancer Sales by Application (2018-2029) & (K Units)
Figure 71. APAC Checkpoint Inhibitors for Treating Cancer Sales Market Share in Volume by Application (2018-2029)
Figure 72. Japan Checkpoint Inhibitors for Treating Cancer Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 73. South Korea Checkpoint Inhibitors for Treating Cancer Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 74. China Taiwan Checkpoint Inhibitors for Treating Cancer Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 75. Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 76. India Checkpoint Inhibitors for Treating Cancer Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 77. Checkpoint Inhibitors for Treating Cancer Value Chain
Figure 78. Checkpoint Inhibitors for Treating Cancer Production Process
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
